[go: up one dir, main page]

SE8704689L - NEW INTERMEDIATES FOR THE MANUFACTURING OF HISTAMINE-H? 712 RECEPTOR ANTAGONISTS AND PROCEDURES FOR PRODUCING THEREOF - Google Patents

NEW INTERMEDIATES FOR THE MANUFACTURING OF HISTAMINE-H? 712 RECEPTOR ANTAGONISTS AND PROCEDURES FOR PRODUCING THEREOF

Info

Publication number
SE8704689L
SE8704689L SE8704689A SE8704689A SE8704689L SE 8704689 L SE8704689 L SE 8704689L SE 8704689 A SE8704689 A SE 8704689A SE 8704689 A SE8704689 A SE 8704689A SE 8704689 L SE8704689 L SE 8704689L
Authority
SE
Sweden
Prior art keywords
histamine
receptor antagonists
procedures
producing
manufacturing
Prior art date
Application number
SE8704689A
Other languages
Swedish (sv)
Other versions
SE8704689D0 (en
SE464302B (en
Inventor
R R Crenshaw
A A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8704689D0 publication Critical patent/SE8704689D0/en
Publication of SE8704689L publication Critical patent/SE8704689L/en
Publication of SE464302B publication Critical patent/SE464302B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Histamine H2-receptor antagonists of the formula <IMAGE> wherein A, m, Z, n and R<1> are as defined herein, and their nontoxic pharmaceutically acceptable salts, hydrates and solvates are novel anti-ulcer agents which are prepared by ring closure of a substituted ethanediimidamide of the formula <IMAGE>
SE8704689A 1982-03-29 1987-11-25 ETHANIIMIDAMIDES AS INTERMEDIATES FOR THE PREPARATION OF HISTAMIN -H2 RECEPTOR ANTAGONISTS AND PROCEDURES FOR THE PRODUCTION OF THEREOF SE464302B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (3)

Publication Number Publication Date
SE8704689D0 SE8704689D0 (en) 1987-11-25
SE8704689L true SE8704689L (en) 1987-11-25
SE464302B SE464302B (en) 1991-04-08

Family

ID=23429274

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8301725A SE461040B (en) 1982-03-29 1983-03-28 SUBSTITUTED 3,4-DIAMINO-1,2,5-THIADIAZOLES AND PROCEDURES FOR PREPARING THEREOF
SE8704689A SE464302B (en) 1982-03-29 1987-11-25 ETHANIIMIDAMIDES AS INTERMEDIATES FOR THE PREPARATION OF HISTAMIN -H2 RECEPTOR ANTAGONISTS AND PROCEDURES FOR THE PRODUCTION OF THEREOF

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8301725A SE461040B (en) 1982-03-29 1983-03-28 SUBSTITUTED 3,4-DIAMINO-1,2,5-THIADIAZOLES AND PROCEDURES FOR PREPARING THEREOF

Country Status (30)

Country Link
JP (2) JPS58180477A (en)
KR (1) KR880002209B1 (en)
AT (1) AT386599B (en)
AU (2) AU557577B2 (en)
BE (1) BE896291A (en)
CH (2) CH655111A5 (en)
CS (2) CS250229B2 (en)
DD (2) DD210909A5 (en)
DE (1) DE3311281A1 (en)
DK (2) DK166677B1 (en)
ES (3) ES520982A0 (en)
FR (2) FR2542741B1 (en)
GB (2) GB2117769B (en)
GR (1) GR78524B (en)
HU (2) HU188742B (en)
IE (1) IE55596B1 (en)
IL (1) IL68259A0 (en)
IT (1) IT1164633B (en)
LU (1) LU84716A1 (en)
MY (1) MY8700942A (en)
NL (1) NL8301063A (en)
NO (1) NO163055C (en)
NZ (1) NZ203726A (en)
OA (1) OA07356A (en)
PT (1) PT76459B (en)
SE (2) SE461040B (en)
SU (2) SU1419518A3 (en)
YU (1) YU44849B (en)
ZA (1) ZA832154B (en)
ZW (1) ZW7683A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (en) * 1986-06-30 1994-03-30 フアナツク株式会社 Direct pressure type mold clamping mechanism
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
FI76795C (en) * 1979-09-04 1988-12-12 Bristol Myers Co Process for the preparation of novel, therapeutically useful 3,4-disubstituted 1,2,5-thiadiazole-1-oxides and -1,1-dioxides and novel intermediates
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
DK81192A (en) 1992-06-18
SU1419518A3 (en) 1988-08-23
JPH06135925A (en) 1994-05-17
KR840004095A (en) 1984-10-06
NZ203726A (en) 1986-05-09
IT1164633B (en) 1987-04-15
DK141383D0 (en) 1983-03-28
AU1290783A (en) 1983-10-06
IL68259A0 (en) 1983-06-15
DD219768A5 (en) 1985-03-13
GB8432809D0 (en) 1985-02-06
GR78524B (en) 1984-09-27
FR2542741B1 (en) 1989-12-08
ZA832154B (en) 1983-12-28
FR2597867A1 (en) 1987-10-30
ES8404683A1 (en) 1984-05-16
ZW7683A1 (en) 1984-01-04
YU44849B (en) 1991-04-30
CH660880A5 (en) 1987-05-29
KR880002209B1 (en) 1988-10-18
IT8348005A0 (en) 1983-03-28
IE830686L (en) 1983-09-29
ES520982A0 (en) 1984-05-16
IE55596B1 (en) 1990-11-21
DK166677B1 (en) 1993-06-28
AT386599B (en) 1988-09-12
PT76459A (en) 1983-04-01
BE896291A (en) 1983-09-28
FR2542741A1 (en) 1984-09-21
NO163055B (en) 1989-12-18
NL8301063A (en) 1983-10-17
NO831100L (en) 1983-09-30
JPS58180477A (en) 1983-10-21
MY8700942A (en) 1987-12-31
NO163055C (en) 1990-03-28
SE8704689D0 (en) 1987-11-25
ES527685A0 (en) 1985-06-16
CS250240B2 (en) 1987-04-16
SU1355123A3 (en) 1987-11-23
SE8301725L (en) 1983-11-25
SE8301725D0 (en) 1983-03-28
PT76459B (en) 1986-03-11
ES8505978A1 (en) 1985-06-16
ES8505977A1 (en) 1985-06-16
AU586037B2 (en) 1989-06-29
SE461040B (en) 1989-12-18
GB2117769B (en) 1985-08-29
GB2117769A (en) 1983-10-19
SE464302B (en) 1991-04-08
OA07356A (en) 1984-08-31
DE3311281A1 (en) 1983-11-24
YU74483A (en) 1986-02-28
ATA111083A (en) 1988-02-15
GB8308518D0 (en) 1983-05-05
HU188742B (en) 1986-05-28
JPH0568472B2 (en) 1993-09-29
AU6327286A (en) 1987-01-08
DK141383A (en) 1983-09-30
CH655111A5 (en) 1986-03-27
DD210909A5 (en) 1984-06-27
AU557577B2 (en) 1986-12-24
ES527686A0 (en) 1985-06-16
HU196386B (en) 1988-11-28
GB2149406A (en) 1985-06-12
CS250229B2 (en) 1987-04-16
DK81192D0 (en) 1992-06-18
FR2597867B1 (en) 1989-12-08
LU84716A1 (en) 1983-12-05
GB2149406B (en) 1986-01-02

Similar Documents

Publication Publication Date Title
SE8005534L (en) QUINOLINE CARBOXYLIC ACID DERIVATIVES AND SETS FOR PREPARING THEREOF
YU881A (en) Process for preparing new sulfonamides
SE7908481L (en) NEW 5H-2,3-BENZODIAZEPINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
HUT56099A (en) Process for producing 2-(2-amino-thiazol-4-yl)-2-(4-pyridon-2-yl-methoxy-imino)-acetic acid derivatives
AU593207B2 (en) Novel phenyl-substituted sulfonamides
ES8602721A1 (en) Process for preparing 1,2,5-thiadiazoles
SE8002293L (en) NEW ANTI-SECRETORIC ASSOCIATIONS AND THEIR SCOPE
SE8704689L (en) NEW INTERMEDIATES FOR THE MANUFACTURING OF HISTAMINE-H? 712 RECEPTOR ANTAGONISTS AND PROCEDURES FOR PRODUCING THEREOF
FI881816A0 (en) NYA BICYCLISKA FOERENINGAR, FOERFARANE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL BLANDNINGAR.
SE8204418L (en) N-IMIDAZOLYL DERIVATIVES OF 1,2,3,4-TETRAHYDRONE AGREEMENT BEFORE AND 2-SUBSTITUTED-1-CHROMAN, AND PROCEDURE FOR THEIR PREPARATION
AU550340B2 (en) Dibenzazepine derivatives
DE3468104D1 (en) New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use
SE8100236L (en) NEW TIOLS AND PROCEDURES FOR PRODUCING THEREOF
ES8702881A1 (en) A PROCEDURE FOR THE PREPARATION OF ETHANODIIMIDAMIDES
CA1228067A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h.sub.2-receptor antagonist activity
SE8300580L (en) SUBSTITUTED 1,3,4-THIADIAZOLO (3,2-A) PYRIMIDINES AND PROCEDURES FOR THEIR PREPARATION
FI810618L (en) NYA KEFALOSPORINER FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA FOERENINGAR INNEHAOLLANDE CEEEMEDEL
FI843363A0 (en) FLAVEN- AND THIOFLAVENDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING, PHARMACEUTICAL PREPARAT INNEHAOLLANDE SAODANA FOERENINGAR OCH ANVAENDNING AV DE SISTNAEMNDA.
DK379581A (en) PROCEDURE FOR THE PREPARATION OF ACYL DERIVATIVES
FI834723A0 (en) NYA HETEROCYCLISKA FOERENINGAR OCH DERAS FRAMSTAELLNING

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8704689-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8704689-2

Format of ref document f/p: F